These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 27405854)
1. The Roles of the Charlson Comorbidity Index and Time to First Antibiotic Dose as Predictors of Outcome in Pneumococcal Community-Acquired Pneumonia. Franzen D; Lim M; Bratton DJ; Kuster SP; Kohler M Lung; 2016 Oct; 194(5):769-75. PubMed ID: 27405854 [TBL] [Abstract][Full Text] [Related]
4. [Community acquired pneumococcal pneumonia in hospitalized adult patients]. Díaz A; Torres C; Flores LJ; García P; Saldías F Rev Med Chil; 2003 May; 131(5):505-14. PubMed ID: 12879811 [TBL] [Abstract][Full Text] [Related]
5. The effect of comorbidities for the prognosis of community-acquired pneumonia: an epidemiologic study using a hospital surveillance in Japan. Nguyen MTN; Saito N; Wagatsuma Y BMC Res Notes; 2019 Dec; 12(1):817. PubMed ID: 31856910 [TBL] [Abstract][Full Text] [Related]
6. Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia. Waterer GW; Kessler LA; Wunderink RG Chest; 2006 Jul; 130(1):11-5. PubMed ID: 16840376 [TBL] [Abstract][Full Text] [Related]
7. Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients: A Matched Case-Control Study. Cillóniz C; Torres A; Manzardo C; Gabarrús A; Ambrosioni J; Salazar A; García F; Ceccato A; Mensa J; de la Bella Casa JP; Moreno A; Miró JM Chest; 2017 Aug; 152(2):295-303. PubMed ID: 28302496 [TBL] [Abstract][Full Text] [Related]
8. Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia. Cillóniz C; Ceccato A; de la Calle C; Gabarrús A; Garcia-Vidal C; Almela M; Soriano A; Martinez JA; Marco F; Vila J; Torres A PLoS One; 2017; 12(8):e0182436. PubMed ID: 28787020 [TBL] [Abstract][Full Text] [Related]
9. Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes. Bordon J; Aliberti S; Duvvuri P; Wiemken T; Peyrani P; Natividad I; Caceres-Lara A; Delapenha R; Blasi F; Ramirez J Int J Infect Dis; 2013 May; 17(5):e293-8. PubMed ID: 23507237 [TBL] [Abstract][Full Text] [Related]
10. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787 [TBL] [Abstract][Full Text] [Related]
11. Pneumonia severity, comorbidity and 1-year mortality in predominantly older adults with community-acquired pneumonia: a cohort study. Wesemann T; Nüllmann H; Pflug MA; Heppner HJ; Pientka L; Thiem U BMC Infect Dis; 2015 Jan; 15():2. PubMed ID: 25566688 [TBL] [Abstract][Full Text] [Related]
12. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience. Ioachimescu OC; Ioachimescu AG; Iannini PB Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482 [TBL] [Abstract][Full Text] [Related]
13. [Severity scores for predicting clinically relevant outcomes for immunocompetent adult patients hospitalized with community-acquired pneumococcal pneumonia]. Saldías F; Díaz O Rev Chilena Infectol; 2011 Aug; 28(4):303-9. PubMed ID: 22052393 [TBL] [Abstract][Full Text] [Related]
15. Severe pneumonia and a second antibiotic. Macfarlane J Lancet; 2002 Apr; 359(9313):1170-2. PubMed ID: 11955532 [No Abstract] [Full Text] [Related]
16. Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia. Naucler P; Darenberg J; Morfeldt E; Ortqvist A; Henriques Normark B Thorax; 2013 Jun; 68(6):571-9. PubMed ID: 23442364 [TBL] [Abstract][Full Text] [Related]
17. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Bordón J; Peyrani P; Brock GN; Blasi F; Rello J; File T; Ramirez J; Chest; 2008 Mar; 133(3):618-24. PubMed ID: 18198264 [TBL] [Abstract][Full Text] [Related]
18. [Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia]. Roger PM; Risso K; Hyvernat H; Landraud L; Vassallo M; Dellamonica J; de Salvador F; Cua E; Bernardin G Med Mal Infect; 2010 Jun; 40(6):347-51. PubMed ID: 20172672 [TBL] [Abstract][Full Text] [Related]
19. Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased? Vallès X; Marcos A; Pinart M; Piñer R; Marco F; Mensa JM; Torres A Chest; 2006 Sep; 130(3):800-6. PubMed ID: 16963678 [TBL] [Abstract][Full Text] [Related]
20. Emergency department crowding is associated with 28-day mortality in community-acquired pneumonia patients. Jo S; Kim K; Lee JH; Rhee JE; Kim YJ; Suh GJ; Jin YH J Infect; 2012 Mar; 64(3):268-75. PubMed ID: 22227383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]